Loxapine film - IntelGenx

Drug Profile

Loxapine film - IntelGenx

Alternative Names: CNS Versafilm™ therapeutic; INT 0036/2012; INT 0036/2013; INT0036

Latest Information Update: 28 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IntelGenx Corp.
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical CNS disorders
  • No development reported Schizophrenia

Most Recent Events

  • 28 Dec 2017 No recent reports of development identified for clinical-Phase-Unknown development in Schizophrenia in Canada (PO, Film)
  • 10 Feb 2016 IntelGenx files for patent protection with US PTO for loxapine oral film
  • 03 Nov 2014 Clinical trials in Schizophrenia in Canada (PO) before November 2014
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top